Gut-Liver Axis in Pediatric Liver Disease: Implications for GLP-1 Research | Retatrutide News

Research on the gut-liver axis in pediatric liver disease may inform GLP-1 agonist development. This could affect drugs like Retatrutide, which target m...
Clinical Trials · October 24, 2026